Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 1
1982 1
1983 1
1984 1
1985 1
1986 1
1988 2
1989 4
1990 4
1991 3
1992 2
1993 5
1994 4
1995 10
1996 4
1997 12
1998 13
1999 10
2000 22
2001 23
2002 21
2003 26
2004 29
2005 46
2006 32
2007 28
2008 20
2009 19
2010 24
2011 18
2012 22
2013 20
2014 19
2015 13
2016 17
2017 13
2018 18
2019 16
2020 12
2021 22
2022 27
2023 20
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

568 results

Results by year

Filters applied: . Clear all
Page 1
Randomised controlled trial to compare efficacy of standard care alone and in combination with homoeopathic treatment of moderate/severe COVID-19 cases.
Kaur H, Bawaskar R, Khobragade A, Kalra D, Packiam V, Khan MY, Kaur T, Sharma M, Verma NK, Kaushik S, Khurana A. Kaur H, et al. PLoS One. 2023 Nov 15;18(11):e0292783. doi: 10.1371/journal.pone.0292783. eCollection 2023. PLoS One. 2023. PMID: 37967089 Free PMC article. Clinical Trial.
Oxygen support was required for 9.847.00 and 14.927.549 days in Homoeopathy and SOC arms, respectively (p<0.005). Subjects receiving Homoeopathy (12.96.days) had a shorter hospitalization stay than in SOC (14.97.5 days). ...The mean score of Clinical Outcome Ordi …
Oxygen support was required for 9.847.00 and 14.927.549 days in Homoeopathy and SOC arms, respectively (p<0.005). Subjects receivi …
Efficacy of homoeopathic treatment: Systematic review of meta-analyses of randomised placebo-controlled homoeopathy trials for any indication.
Hamre HJ, Glockmann A, von Ammon K, Riley DS, Kiene H. Hamre HJ, et al. Syst Rev. 2023 Oct 7;12(1):191. doi: 10.1186/s13643-023-02313-2. Syst Rev. 2023. PMID: 37805577 Free PMC article.
Statistical analyses were performed to determine the proportion of MAs showing a significant positive effect of homoeopathy vs. no significant difference. RESULTS: Six MAs were included, covering individualised homoeopathy (I-HOM, n = 2), nonindividualised homoeo
Statistical analyses were performed to determine the proportion of MAs showing a significant positive effect of homoeopathy vs. no si …
Recommendations in the design and conduction of randomised controlled trials in human and veterinary homeopathic medicine.
Gaertner K, von Ammon K, Fibert P, Frass M, Frei-Erb M, Klein-Laansma C, Ulbrich-Zuerni S, Weiermayer P. Gaertner K, et al. Complement Ther Med. 2023 Sep;76:102961. doi: 10.1016/j.ctim.2023.102961. Epub 2023 Jul 1. Complement Ther Med. 2023. PMID: 37393961 Free article. Review.
OBJECTIVES: This paper aims to fill this gap in order to enhance the quality of RCTs in the field of homeopathy. METHODS: Identification of the homeopathy-specific requirements for RCTs by reviewing literature and experts' communications. ...Consideration of the REF …
OBJECTIVES: This paper aims to fill this gap in order to enhance the quality of RCTs in the field of homeopathy. METHODS: Identificat …
Individualized Homeopathic Medicines in the Treatment of Psoriasis Vulgaris: Double-Blind, Randomized, Placebo-Controlled Trial.
Balamurugan D, Nayak C, Chattopadhyay A, Karuppusamy A, Ambrose MM, Kumar A, Singh NK, Koley M, Saha S. Balamurugan D, et al. Complement Med Res. 2023;30(4):317-331. doi: 10.1159/000530180. Epub 2023 Jun 1. Complement Med Res. 2023. PMID: 37263249 Clinical Trial. English.
Worldwide prevalence ranges between 0.1 and 11.4%, and in India between 0.4 and 2.8%; this creates a serious health burden. Psoriasis remains a frequently encountered condition in homeopathy practice, but there is a dearth of conclusive efficacy data supporting its use. ME …
Worldwide prevalence ranges between 0.1 and 11.4%, and in India between 0.4 and 2.8%; this creates a serious health burden. Psoriasis remain …
Homeopathy for Major Depressive Disorder: Protocol for N-of-1 Studies.
Adler UC, Adler MS, Cesar AT, Santos HF, Magalhães PADF, Nogueira RDS, Campos EM, Viana Júnior AB, Sanders LLO. Adler UC, et al. Complement Med Res. 2023;30(4):332-339. doi: 10.1159/000531072. Epub 2023 May 16. Complement Med Res. 2023. PMID: 37231828 English.
Crossover study: the participant will go through three consecutive treatment blocks, with two random and masked treatment periods (A or B), corresponding to homeopathy or placebo. Treatment periods will have 2, 4, and 8 weeks in the first, second, and third blocks, respect …
Crossover study: the participant will go through three consecutive treatment blocks, with two random and masked treatment periods (A or B), …
Efficacy of Individualized Homeopathic Medicines in the Treatment of Menopausal Syndrome: Double-Blind, Randomized, Placebo-Controlled Trial.
Ghosh S, Palanisamy C, Das AD, Mandal S, Guha N, Maiti S, Ghosh P, Singh NK, Koley M, Saha S. Ghosh S, et al. J Integr Complement Med. 2023 Oct;29(10):649-664. doi: 10.1089/jicm.2022.0760. Epub 2023 May 24. J Integr Complement Med. 2023. PMID: 37222798 Clinical Trial.
Objectives: Menopausal symptoms are systemic symptoms that are associated with estrogen deficiency after menopause. Although widely practiced, homeopathy remains under-researched in menopausal syndrome in terms of quality evidence, especially in randomized trials. ...
Objectives: Menopausal symptoms are systemic symptoms that are associated with estrogen deficiency after menopause. Although widely practice …
568 results